BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1942 related articles for article (PubMed ID: 9626662)

  • 21. Characterization of receptor-interacting protein 140 in retinoid receptor activities.
    Lee CH; Wei LN
    J Biol Chem; 1999 Oct; 274(44):31320-6. PubMed ID: 10531331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor alpha and liver-X-receptor alpha.
    Miyata KS; McCaw SE; Meertens LM; Patel HV; Rachubinski RA; Capone JP
    Mol Cell Endocrinol; 1998 Nov; 146(1-2):69-76. PubMed ID: 10022764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COUP-TF II homodimers are formed in preference to heterodimers with RXR alpha or TR beta in intact cells.
    Butler AJ; Parker MG
    Nucleic Acids Res; 1995 Oct; 23(20):4143-50. PubMed ID: 7479078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors.
    Hong H; Kohli K; Garabedian MJ; Stallcup MR
    Mol Cell Biol; 1997 May; 17(5):2735-44. PubMed ID: 9111344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
    Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE
    Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional evidence for retinoid X receptor (RXR) as a nonsilent partner in the thyroid hormone receptor/RXR heterodimer.
    Li D; Li T; Wang F; Tian H; Samuels HH
    Mol Cell Biol; 2002 Aug; 22(16):5782-92. PubMed ID: 12138189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity.
    Farooqui M; Franco PJ; Thompson J; Kagechika H; Chandraratna RA; Banaszak L; Wei LN
    Biochemistry; 2003 Feb; 42(4):971-9. PubMed ID: 12549917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A permissive retinoid X receptor/thyroid hormone receptor heterodimer allows stimulation of prolactin gene transcription by thyroid hormone and 9-cis-retinoic acid.
    Castillo AI; Sánchez-Martínez R; Moreno JL; Martínez-Iglesias OA; Palacios D; Aranda A
    Mol Cell Biol; 2004 Jan; 24(2):502-13. PubMed ID: 14701725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoid receptors in health and disease: co-regulators and the chromatin connection.
    Minucci S; Pelicci PG
    Semin Cell Dev Biol; 1999 Apr; 10(2):215-25. PubMed ID: 10441075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
    Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
    J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT5b down-regulates peroxisome proliferator-activated receptor alpha transcription by inhibition of ligand-independent activation function region-1 trans-activation domain.
    Zhou YC; Waxman DJ
    J Biol Chem; 1999 Oct; 274(42):29874-82. PubMed ID: 10514468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allosteric regulation of the discriminative responsiveness of retinoic acid receptor to natural and synthetic ligands by retinoid X receptor and DNA.
    Mouchon A; Delmotte MH; Formstecher P; Lefebvre P
    Mol Cell Biol; 1999 Apr; 19(4):3073-85. PubMed ID: 10082574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPAR gamma/RXR as a molecular target for diabetes.
    Lenhard JM
    Recept Channels; 2001; 7(4):249-58. PubMed ID: 11697231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transactivation by PPAR/RXR heterodimers in yeast is potentiated by exogenous fatty acid via a pathway requiring intact peroxisomes.
    Marcus SL; Miyata KS; Rachubinski RA; Capone JP
    Gene Expr; 1995; 4(4-5):227-39. PubMed ID: 7787415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter.
    Kim HI; Kim JW; Kim SH; Cha JY; Kim KS; Ahn YH
    Diabetes; 2000 Sep; 49(9):1517-24. PubMed ID: 10969836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo.
    Lee SK; Anzick SL; Choi JE; Bubendorf L; Guan XY; Jung YK; Kallioniemi OP; Kononen J; Trent JM; Azorsa D; Jhun BH; Cheong JH; Lee YC; Meltzer PS; Lee JW
    J Biol Chem; 1999 Nov; 274(48):34283-93. PubMed ID: 10567404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
    Herdick M; Carlberg C
    J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins.
    Schaufele F
    Mol Endocrinol; 1999 Jun; 13(6):935-45. PubMed ID: 10379892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular context of coregulator and adaptor proteins regulates human adenovirus 5 early region 1A-dependent gene activation by the thyroid hormone receptor.
    Meng X; Yang YF; Cao X; Govindan MV; Shuen M; Hollenberg AN; Mymryk JS; Walfish PG
    Mol Endocrinol; 2003 Jun; 17(6):1095-105. PubMed ID: 12637585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 98.